187 related articles for article (PubMed ID: 18421308)
1. A chimeric fusion of the hASH1 and EZH2 promoters mediates high and specific reporter and suicide gene expression and cytotoxicity in small cell lung cancer cells.
Poulsen TT; Pedersen N; Juel H; Poulsen HS
Cancer Gene Ther; 2008 Sep; 15(9):563-75. PubMed ID: 18421308
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific expression of human achaete-scute homologue-1 in neuroendocrine tumors: transcriptional regulation by dual inhibitory regions.
Chen H; Biel MA; Borges MW; Thiagalingam A; Nelkin BD; Baylin SB; Ball DW
Cell Growth Differ; 1997 Jun; 8(6):677-86. PubMed ID: 9186001
[TBL] [Abstract][Full Text] [Related]
3. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
[TBL] [Abstract][Full Text] [Related]
4. Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression.
Chen H; Thiagalingam A; Chopra H; Borges MW; Feder JN; Nelkin BD; Baylin SB; Ball DW
Proc Natl Acad Sci U S A; 1997 May; 94(10):5355-60. PubMed ID: 9144241
[TBL] [Abstract][Full Text] [Related]
5. Insights into the achaete-scute homolog-1 gene (hASH1) in normal and neoplastic human lung.
Miki M; Ball DW; Linnoila RI
Lung Cancer; 2012 Jan; 75(1):58-65. PubMed ID: 21684625
[TBL] [Abstract][Full Text] [Related]
6. Notch signaling induces rapid degradation of achaete-scute homolog 1.
Sriuranpong V; Borges MW; Strock CL; Nakakura EK; Watkins DN; Blaumueller CM; Nelkin BD; Ball DW
Mol Cell Biol; 2002 May; 22(9):3129-39. PubMed ID: 11940670
[TBL] [Abstract][Full Text] [Related]
7. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
[TBL] [Abstract][Full Text] [Related]
8. The balance between the expressions of hASH1 and HES1 differs between large cell neuroendocrine carcinoma and small cell carcinoma of the lung.
Nasgashio R; Sato Y; Matsumoto T; Kageyama T; Hattori M; Iyoda A; Satoh Y; Ryuge S; Masuda N; Jiang SX; Saegusa M
Lung Cancer; 2011 Dec; 74(3):405-10. PubMed ID: 21601304
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma-specific cytotoxicity mediated by the Mash1-promoter and E. coli purine nucleoside phosphorylase.
Arvidsson Y; Sumantran V; Watt F; Uramoto H; Funa K
Pediatr Blood Cancer; 2005 Jan; 44(1):77-84. PubMed ID: 15390277
[TBL] [Abstract][Full Text] [Related]
10. Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.
Ball DW; Azzoli CG; Baylin SB; Chi D; Dou S; Donis-Keller H; Cumaraswamy A; Borges M; Nelkin BD
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5648-52. PubMed ID: 8390674
[TBL] [Abstract][Full Text] [Related]
11. Single agent- and combination treatment with two targeted suicide gene therapy systems is effective in chemoresistant small cell lung cancer cells.
Michaelsen SR; Christensen CL; Sehested M; Cramer F; Poulsen TT; Patterson AV; Poulsen HS
J Gene Med; 2012 Jul; 14(7):445-58. PubMed ID: 22576955
[TBL] [Abstract][Full Text] [Related]
12. Notch signaling induces cell cycle arrest in small cell lung cancer cells.
Sriuranpong V; Borges MW; Ravi RK; Arnold DR; Nelkin BD; Baylin SB; Ball DW
Cancer Res; 2001 Apr; 61(7):3200-5. PubMed ID: 11306509
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated suicide SCLC gene therapy using the increased activity of the hTERT promoter by the MMRE and SV40 enhancer.
Song JS
Biosci Biotechnol Biochem; 2005 Jan; 69(1):56-62. PubMed ID: 15665468
[TBL] [Abstract][Full Text] [Related]
14. E-box motifs within the human vasopressin gene promoter contribute to a major enhancer in small-cell lung cancer.
Coulson JM; Fiskerstrand CE; Woll PJ; Quinn JP
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):961-70. PubMed ID: 10585887
[TBL] [Abstract][Full Text] [Related]
15. EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin.
Tong ZT; Cai MY; Wang XG; Kong LL; Mai SJ; Liu YH; Zhang HB; Liao YJ; Zheng F; Zhu W; Liu TH; Bian XW; Guan XY; Lin MC; Zeng MS; Zeng YX; Kung HF; Xie D
Oncogene; 2012 Feb; 31(5):583-94. PubMed ID: 21685935
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinicopathologic significance of human achaete-scute homolog 1 in pulmonary neuroendocrine tumors].
Li F; Zhong Z; Li R; Huang H; Wang L; Zheng D; Zhang D
Zhongguo Fei Ai Za Zhi; 2010 Apr; 13(4):317-21. PubMed ID: 20677557
[TBL] [Abstract][Full Text] [Related]
17. Enhancer of zeste homolog 2 downregulates E-cadherin by mediating histone H3 methylation in gastric cancer cells.
Fujii S; Ochiai A
Cancer Sci; 2008 Apr; 99(4):738-46. PubMed ID: 18377425
[TBL] [Abstract][Full Text] [Related]
18. Tumour-specific arginine vasopressin promoter activation in small-cell lung cancer.
Coulson JM; Stanley J; Woll PJ
Br J Cancer; 1999 Aug; 80(12):1935-44. PubMed ID: 10471042
[TBL] [Abstract][Full Text] [Related]
19. hASH1 is a specific immunohistochemical marker for lung neuroendocrine tumors.
Ye B; Cappel J; Findeis-Hosey J; McMahon L; Yang Q; Xiao GQ; Xu H; Li F
Hum Pathol; 2016 Feb; 48():142-7. PubMed ID: 26596584
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder.
Raman JD; Mongan NP; Tickoo SK; Boorjian SA; Scherr DS; Gudas LJ
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8570-6. PubMed ID: 16361539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
